Author | Jared Kaltwasser


Use of Triplet Therapy Rose in R/R MM as Deaths Declined, Study Finds

October 29, 2020

Newer therapies have led to a boost in the number of patients with relapsed or refractory multiple myeloma (R/R MM) who are prescribed triplet regimens. As that shift has occurred, death rates appear to have dropped.